TCHP and neoplasm: Tumor cells generally display different molecular changes, which include overexpression of cyclins, cyclin-dependent kinases (CDKs), loss of CDK inhibitors, and tumor-suppressor proteins such as p53 due to epigenetic inactivation or gene mutations [41].